Cited by 42Endometriosis Research and TreatmentReproductive Biology and FertilityReproductive Health and Technologies

Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist

Kolanska, K., Cohen, J., Bendifallah, S., Selleret, L., Antoine, J.-M., Chabbert-Buffet, N., Darai, E., d’Argent, E.-M.·2017·Journal of Gynecology Obstetrics and Human Reproduction

Abstract

Background or objective Endometriosis is common in women referred for infertility. In vitro fertilization provides good results but the choice of the best-controlled ovarian hyperstimulation protocol remains a subject of debate. The objective of this retrospective study was to compare pregnancy outcomes in women with endometriosis-associated infertility after COH with a long agonist protocol or a six-week oral contraception-antagonist protocol.Material and methods Retrospective analysis of a prospective database identified 284 COH cycles - 165 with GnRH-agonist protocol (GnRH-agonist group) and 119 with GnRH-antagonist protocol (GnRH-antagonist group) - in 218 women, with endometriosis from January 2013 to October 2015.Results No difference in the epidemiological characteristics was found between the groups. Per started cycle, pregnancy and live-birth rates after fresh embryo transfer were higher with the GnRH-agonist protocol (25% vs. 13%, P=0.02 and 18% vs. 8%, P=0.04, respectively). Considering analysis per cycle with embryo transfer, the pregnancy rate was similar in both groups while the live-birth rate was higher in the GnRH-agonist group (29% vs. 17%, P=0.053 and 22% vs. 10%, P=0.02, respectively). No difference was observed between the groups with freeze-thaw embryo transfer. Subgroup analysis (endometrioma alone, deep infiltrating endometriosis with and without endometrioma, endometriosis with and without adenomyosis) revealed no difference between the groups for either pregnancy or live-birth rates.Conclusion A GnRH-agonist protocol appears to result in higher pregnancy and live-birth rates after fresh embryo transfer in women with endometriosis-associated infertility, suggesting that a GnRH-antagonist protocol might negatively impact endometrial receptivity.

Integrity signals

Registry

Crossref · 10.1016/j.jogoh.2017.09.007

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Embryo transfers conducted in estradiol and progesterone cycles may have a beneficial effect on endometrial receptivity.

    “Indeed, embryo transfers conducted in E 2 and progesterone cycles may have a beneficial effect on endometrial receptivity.”

    From Endometrial receptivity in adenomyosis and/or endometriosis (2023) · cites this paper as [58]

  • A few reports suggest GnRH agonist protocols offer higher pregnancy and live birth rates than GnRH antagonist protocols.

    “Of note, a few reports, however, suggested that GnRH-a protocols offer higher pregnancy and LBR than those offered by GnRH-antagonist protocols (58,59).”

    From Endometrial receptivity in adenomyosis and/or endometriosis (2023) · cites this paper as [58]

Cites

Flagged first, then by citations

3 of the 34 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kolanska, K., Cohen, J., Bendifallah, S., Selleret, L., Antoine, J.-M., Chabbert-Buffet, N., Darai, E., & d’Argent, E.-M.
Affiliations
Assistance Publique – Hôpitaux de Paris (FR)
Corresponding author
Cohen, J.
Venue
Journal of Gynecology Obstetrics and Human Reproduction
Publisher
Elsevier BV
Published
2017-11
Volume
46
Issue
9
Pages
681-686
ISSN
2468-7847 (ISSN-L)
OpenAlex
W2757880901
Cited by
42
References
34
Citations by year
2026: 3 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 10 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 4
FWCI
2.86
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Gynecology Obstetrics and Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
Keywords
endometriosis-associated infertility, controlled ovarian stimulation, GnRH agonist protocol, GnRH antagonist protocol, pregnancy rate, live birth rate, fresh embryo transfer, frozen embryo transfer, endometrial receptivity, deep infiltrating endometriosis, endometrioma, adenomyosis
MeSH terms
Adult, Endometriosis, Female, Fertility Agents, Female, Fertilization in Vitro, Hormone Antagonists, Humans, Infertility, Gonadotropin-Releasing Hormone, Male, Ovulation Induction, Pregnancy, Pregnancy Outcome, Retrospective Studies, Uterine Diseases, Pregnancy Rate, Sperm Injections, Intracytoplasmic, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review